Skip to content

Effect of Curcumin associated with LED application in the treatment of residual pockets of patients with Chronic Periodontitis and type 2 Diabetes Mellitus

Photodynamic effects of Curcumin in the treatment of residual pockets in patients with Chronic Periodontitis and type 2 Diabetes Mellitus: a randomized split-mouth trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4tq9yq
Enrollment
Unknown
Registered
2018-08-06
Start date
2017-06-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis, Diabetes Mellitus

Interventions

This is a split-mouth desing study in which twenty-five diabetics with chronic periodontitis on supportive periodontal therapy were selected (HbA1c bigger or equal to 6, 5%). In each patient, all resi
(2) SRP in single session and irrigation with Curcumin 100 mg/ml solution (CUR Group)
(3) SRP in single session, irrigation with saline solution and irradiation with LED (LED group)
(4) SRP in single session, irrigation with CUR solution, followed by LED irradiation (aPDT Group). The antimicrobial photodynamic therapy (aPDT) was performed using CUR (100 mg / ml) followed by LED i
Procedure/surgery
Other
E06.721.189.350
E02.186.500

Sponsors

Universidade Estadual Paulista (Unesp), Faculdade de Odontologia, Araçatuba
Lead Sponsor
Universidade Estadual Paulista (Unesp), Faculdade de Odontologia, Araçatuba
Collaborator

Eligibility

Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with age equal to or greater than 30 years and less or equal than 70 years (MATARAZZO et al., 2008); diagnosis of chronic periodontitis that have undergone periodontal treatment in a period of 3 to 6 months, with at least 4 sites with probing depth (PD) bigger or equal than 5 mm and loss of clinical attachment (CAL) bigger or equal than 3 mm with bleeding on probing (BOP) (APP, 2015); patients diagnosed with type 2 diabetes mellitus (HbA1c equal to or greater than 6.5%) (SACKS et al., 2011); present at least 15 teeth, excluding third molars (ASSEM, 2015); at least 1 site with PD equal to or greater than 5 mm (residual pocket with bleeding on probing) per quadrant.

Exclusion criteria

Exclusion criteria: Smokers or ex-smokers for more than 12 months; patients with anemia; patient with active cancer and history of chemotherapy; history of antibiotic therapy in the previous 6 months; history of anti-inflammatory therapy in the last 6 months; patient with blood disorders; pregnancy; patient in orthodontic treatment.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be the mean of changes in the level of clinical attachment in moderate and deep pockets.

Secondary

MeasureTime frame
Clinical evaluation of visible plaque index, bleeding on probing, gingival recession and probing depth after 90 and 180 days of periodontal treatment.

Countries

Brazil

Contacts

Public ContactLeticia Theodoro

Universidade Estadual Paulista (Unesp), Faculdade de Odontologia, Araçatuba

letheodoro@foa.unesp.br+55-018-36363200

Outcome results

None listed

Source: REBEC (via WHO ICTRP)